Literature DB >> 12845617

The myofibroblast in wound healing and fibrocontractive diseases.

G Gabbiani1.   

Abstract

The demonstration that fibroblastic cells acquire contractile features during the healing of an open wound, thus modulating into myofibroblasts, has open a new perspective in the understanding of mechanisms leading to wound closure and fibrocontractive diseases. Myofibroblasts synthesize extracellular matrix components such as collagen types I and III and during normal wound healing disappear by apoptosis when epithelialization occurs. The transition from fibroblasts to myofibroblasts is influenced by mechanical stress, TGF-beta and cellular fibronectin (ED-A splice variant). These factors also play important roles in the development of fibrocontractive changes, such as those observed in liver cirrhosis, renal fibrosis, and stroma reaction to epithelial tumours. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12845617     DOI: 10.1002/path.1427

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  488 in total

Review 1.  The extracellular matrix: an active or passive player in fibrosis?

Authors:  Thomas N Wight; Susan Potter-Perigo
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-04-21       Impact factor: 4.052

Review 2.  Extra-cellular matrix in vascular networks.

Authors:  George Bou-Gharios; Markella Ponticos; Vineeth Rajkumar; David Abraham
Journal:  Cell Prolif       Date:  2004-06       Impact factor: 6.831

3.  Thy-1 expression regulates the ability of rat lung fibroblasts to activate transforming growth factor-beta in response to fibrogenic stimuli.

Authors:  Yong Zhou; James S Hagood; Joanne E Murphy-Ullrich
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

Review 4.  Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities.

Authors:  Swati Bhattacharyya; Jun Wei; John Varga
Journal:  Nat Rev Rheumatol       Date:  2011-10-25       Impact factor: 20.543

5.  Mechanotransduction is enhanced by the synergistic action of heterotypic cell interactions and TGF-β1.

Authors:  Jacquelyn Youssef; Peng Chen; Vivek B Shenoy; Jeffrey R Morgan
Journal:  FASEB J       Date:  2012-02-28       Impact factor: 5.191

6.  Visceral and somatic disorders: tissue softening with frequency-specific microcurrent.

Authors:  Carolyn R McMakin; James L Oschman
Journal:  J Altern Complement Med       Date:  2012-07-09       Impact factor: 2.579

7.  Immunotherapy of tumor with vaccine based on basic fibroblast growth factor-activated fibroblasts.

Authors:  Xiuying Li; Yongsheng Wang; Yuwei Zhao; Hengxiu Yang; Aiping Tong; Chengjian Zhao; Huashan Shi; Yang Li; Zhenlin Wang; Yuquan Wei
Journal:  J Cancer Res Clin Oncol       Date:  2013-12-10       Impact factor: 4.553

8.  Novel Rho/MRTF/SRF inhibitors block matrix-stiffness and TGF-β-induced fibrogenesis in human colonic myofibroblasts.

Authors:  Laura A Johnson; Eva S Rodansky; Andrew J Haak; Scott D Larsen; Richard R Neubig; Peter D R Higgins
Journal:  Inflamm Bowel Dis       Date:  2014-01       Impact factor: 5.325

9.  Alcohol ingestion by donors amplifies experimental airway disease after heterotopic transplantation.

Authors:  Patrick O Mitchell; David M Guidot
Journal:  Am J Respir Crit Care Med       Date:  2007-08-23       Impact factor: 21.405

10.  Protein Tyrosine Phosphatase-N13 Promotes Myofibroblast Resistance to Apoptosis in Idiopathic Pulmonary Fibrosis.

Authors:  Alison Bamberg; Elizabeth F Redente; Steve D Groshong; Rubin M Tuder; Carlyne D Cool; Rebecca C Keith; Benjamin L Edelman; Bart P Black; Gregory P Cosgrove; Murry W Wynes; Douglas Curran-Everett; Stijn De Langhe; Luis A Ortiz; Andrew Thorburn; David W H Riches
Journal:  Am J Respir Crit Care Med       Date:  2018-10-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.